Company intelligence / Profile preview

NX Gen

Grand Rapids, Michigan, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

NxGen MDx is a leading women's health genetic testing company that provides actionable diagnostic information to physicians and patients. The company specializes in advanced screening technologies, including carrier screening, hereditary cancer testing, and prenatal diagnostics, utilizing high-throughput next-generation sequencing (NGS). By focusing on accuracy and accessibility, NxGen MDx aims to empower families with genetic insights to guide reproductive and health management decisions. Their clinical laboratory is CLIA-certified and CAP-accredited, ensuring high standards for molecular diagnostic services.

Therapeutic areas: OncologyNeurologyWomen's HealthPulmonology
Modalities: Genetic testingNext-generation sequencingMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on NX Gen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NX Gen.

Explore the full profile